Stockscreener 앱 받기
4.60
0.86%
-0.04
시간 외 거래:
4.61
0.01
+0.22%
전일 마감가:
$4.64
열려 있는:
$4.45
하루 거래량:
3.49M
Relative Volume:
2.37
시가총액:
$210.30M
수익:
$27.10M
순이익/손실:
$-24.31M
주가수익비율:
-5.5422
EPS:
-0.83
순현금흐름:
$-33.33M
1주 성능:
-18.44%
1개월 성능:
-25.81%
6개월 성능:
-55.12%
1년 성능:
-75.56%
1일 변동 폭
$4.30
$4.84
1주일 범위
$4.30
$6.01
52주 변동 폭
$4.30
$20.75
Capricor Therapeutics Inc Stock (CAPR) Company Profile
명칭
Capricor Therapeutics Inc
전화
(310) 358-3200
주소
10865 ROAD TO THE CURE, SAN DIEGO, CA
CAPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CAPR
Capricor Therapeutics Inc
|
4.60 | 212.13M | 27.10M | -24.31M | -33.33M | -0.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 개시 | Alliance Global Partners | Buy |
| 2025-06-26 | 개시 | B. Riley Securities | Buy |
| 2025-05-20 | 개시 | Roth Capital | Buy |
| 2024-10-21 | 개시 | Piper Sandler | Overweight |
| 2024-05-17 | 개시 | Oppenheimer | Outperform |
| 2024-01-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-10-26 | 개시 | Ladenburg Thalmann | Buy |
| 2018-12-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-15 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-13 | 재개 | Rodman & Renshaw | Buy |
| 2016-07-06 | 재개 | H.C. Wainwright | Buy |
| 2016-06-15 | 개시 | ROTH Capital | Buy |
모두보기
Capricor Therapeutics Inc 주식(CAPR)의 최신 뉴스
Unpacking the Latest Options Trading Trends in Capricor Therapeutics - Benzinga
Martin Shkreli Takes Aim At Capricor — Stock Sinks - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17% - Stocktwits
Capricor Therapeutics (CAPR) Stock Is Sliding Today: Should Retail Investors Be Worried? - inkl
Capricor Therapeutics stock tumbles after Martin Shkreli short call - Investing.com
Capricor Therapeutics stock tumbles after Martin Shkreli short call By Investing.com - Investing.com Canada
Capricor presents scalable framework for loading therapeutics into exosomes - Investing.com India
Capricor Therapeutics (CAPR) Showcases Scalable Exosome Loading Framework - GuruFocus
Capricor Therapeutics Presents New Data Demonstrating a - GlobeNewswire
Precision Trading with Capricor Therapeutics Inc. (CAPR) Risk Zones - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeuti - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Can Capricor Therapeutics Inc. stock attract ESG capital inflowsCEO Change & Precise Entry and Exit Recommendations - newser.com
How high can Capricor Therapeutics Inc. stock go2025 Big Picture & Technical Buy Zone Confirmation - newser.com
Is Capricor Therapeutics Inc. (4LN2) stock undervalued by metricsPortfolio Profit Report & Safe Capital Growth Tips - newser.com
Will Capricor Therapeutics Inc. price bounce be sustainableRecession Risk & Fast Exit/Entry Strategy Plans - newser.com
Capricor Therapeutics Inc.’s volatility index tracking explainedTrade Exit Summary & Daily Technical Stock Forecast Reports - newser.com
How big funds are accumulating Capricor Therapeutics Inc. (4LN2) stockOil Prices & Short-Term High Return Ideas - newser.com
How Capricor Therapeutics Inc. stock reacts to oil pricesShare Buyback & Capital Efficient Trading Techniques - newser.com
What valuation multiples suggest for Capricor Therapeutics Inc. stockRisk Management & Daily Growth Stock Tips - newser.com
Is Capricor Therapeutics Inc. (4LN2) stock a momentum leader2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Will Capricor Therapeutics Inc. stock benefit from upcoming earnings reports2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Capricor Therapeutics Inc. (CAPR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Published on: 2025-11-19 06:48:13 - newser.com
What insider purchases suggest about Capricor Therapeutics Inc. (4LN2) stockJuly 2025 Gainers & Verified Technical Signals - newser.com
What hedge fund moves indicate for Capricor Therapeutics Inc. (4LN2) stockTrade Volume Report & Smart Allocation Stock Reports - newser.com
Smart tools for monitoring Capricor Therapeutics Inc.’s price action2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
Strategies to average down on Capricor Therapeutics Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Will Capricor Therapeutics Inc. (4LN2) stock announce a stock splitWeekly Gains Report & Smart Money Movement Tracker - newser.com
Is Capricor Therapeutics Inc. (4LN2) stock cheap by valuation metricsJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Connect - ACCESS Newswire
Published on: 2025-11-18 02:20:40 - newser.com
Capricor Therapeutics Inc (CAPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
1.88%
자본화:
|
볼륨(24시간):